- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- May 2025
- 182 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 202 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- April 2025
- 381 Pages
Global
From €3665EUR$4,197USD£3,184GBP
- Report
- August 2025
- 199 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 191 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 199 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 187 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2025
- 389 Pages
Global
From €3665EUR$4,197USD£3,184GBP
- Report
- February 2025
- 190 Pages
Global
From €4191EUR$4,799USD£3,641GBP
- Report
- June 2025
- 325 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- July 2025
- 128 Pages
Global
From €4279EUR$4,900USD£3,717GBP
- Report
- April 2025
- 144 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- April 2025
- 138 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- December 2024
- 110 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- April 2025
- 120 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- November 2024
- 100 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- October 2024
- 150 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 185 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP

The Mesenchymal Stem Cell (MSC) market is a rapidly growing sector of the genomics industry. MSCs are multipotent cells that can differentiate into a variety of cell types, including bone, cartilage, and fat. They are used in regenerative medicine, tissue engineering, and drug discovery. MSCs are also being studied for their potential to treat a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases.
The MSC market is driven by advances in genomics technology, such as gene editing and sequencing, which have enabled researchers to better understand the biology of MSCs and develop new therapeutic applications. Additionally, the increasing demand for personalized medicine and the growing awareness of the potential of MSCs to treat a variety of diseases are driving the growth of the MSC market.
Some of the major companies in the MSC market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. Show Less Read more